1. A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109). Issue 2 (February 2015) Authors: Hattori, Yoshihiro; Satouchi, Miyako; Shimada, Temiko; Urata, Yoshiko; Yoneda, Tsutomu; Mori, Masahide; Nishimura, Takashi; Sunadome, Hironobu; Kumagai, Toru; Imamura, Fumio; Fujita, Shiro; Kaji, Reiko; Hata, Akito; Tachihara, Motoko; Morita, Satoshi; Negoro, Shunichi Journal: Lung cancer Issue: Volume 87:Issue 2(2015:Feb.) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109). Issue 2 (February 2015) Authors: Hattori, Yoshihiro; Satouchi, Miyako; Shimada, Temiko; Urata, Yoshiko; Yoneda, Tsutomu; Mori, Masahide; Nishimura, Takashi; Sunadome, Hironobu; Kumagai, Toru; Imamura, Fumio; Fujita, Shiro; Kaji, Reiko; Hata, Akito; Tachihara, Motoko; Morita, Satoshi; Negoro, Shunichi Journal: Lung cancer Issue: Volume 87:Issue 2(2015:Feb.) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110). Issue 2 (August 2015) Authors: Nishino, Kazumi; Imamura, Fumio; Kumagai, Toru; Katakami, Nobuyuki; Hata, Akito; Okuda, Chiyuki; Urata, Yoshiko; Hattori, Yosihihiro; Tachihara, Motoko; Yokota, Souichirou; Nishimura, Takashi; Kaneda, Toshihiko; Satouchi, Miyako; Morita, Satoshi; Negoro, Shunichi Journal: Lung cancer Issue: Volume 89:Issue 2(2015:Aug.) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bevacizumab beyond disease progression after first‐line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non–small cell lung cancer (West Japan Oncology Group 5910L): An open‐label, randomized, phase 2 trial. Issue 7 (1st February 2016) Authors: Takeda, Masayuki; Yamanaka, Takeharu; Seto, Takashi; Hayashi, Hidetoshi; Azuma, Koichi; Okada, Morihito; Sugawara, Shunichi; Daga, Haruko; Hirashima, Tomonori; Yonesaka, Kimio; Urata, Yoshiko; Murakami, Haruyasu; Saito, Haruhiro; Kubo, Akihito; Sawa, Toshiyuki; Miyahara, Eiji; Nogami, Naoyuki; Na... Journal: Cancer Issue: Volume 122:Issue 7(2016) Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing. (February 2019) Authors: Mizugaki, Hidenori; Hamada, Akinobu; Shibata, Tatsuhiro; Hosoda, Fumie; Nakamura, Hiromi; Okuma, Yusuke; Shukuya, Takehito; Umemura, Shigeki; Horiike, Atsushi; Fukui, Tomoya; Kogure, Yoshihito; Daga, Haruko; Urata, Yoshiko; Yamada, Kazuhiko; Saeki, Sho; Fujisaka, Yasuhito; Nakamura, Yukiko; Sato,... Journal: Lung cancer Issue: Volume 128(2019) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase 2 study of S‐1 and carboplatin plus bevacizumab followed by maintenance S‐1 and bevacizumab for chemotherapy‐naive patients with advanced nonsquamous non–small cell lung cancer. Issue 12 (4th April 2013) Authors: Urata, Yoshiko; Okamoto, Isamu; Takeda, Masayuki; Hattori, Yoshihiro; Okuno, Keiko; Shimada, Temiko; Kurata, Takayasu; Kaneda, Hiroyasu; Miyazaki, Masaki; Terashima, Masaaki; Tanaka, Kaoru; Morita, Satoshi; Nakagawa, Kazuhiko; Negoro, Shunichi; Satouchi, Miyako Journal: Cancer Issue: Volume 119:Issue 12(2013) Page Start: 2275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase 2 study of S‐1 and carboplatin plus bevacizumab followed by maintenance S‐1 and bevacizumab for chemotherapy‐naive patients with advanced nonsquamous non–small cell lung cancer. Issue 12 (4th April 2013) Authors: Urata, Yoshiko; Okamoto, Isamu; Takeda, Masayuki; Hattori, Yoshihiro; Okuno, Keiko; Shimada, Temiko; Kurata, Takayasu; Kaneda, Hiroyasu; Miyazaki, Masaki; Terashima, Masaaki; Tanaka, Kaoru; Morita, Satoshi; Nakagawa, Kazuhiko; Negoro, Shunichi; Satouchi, Miyako Journal: Cancer Issue: Volume 119:Issue 12(2013) Page Start: 2275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗